Published in Handb Clin Neurol on January 01, 2007
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
HIV-1 infection and cognitive impairment in the cART era: a review. AIDS (2011) 1.72
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
Introduction: HIV/AIDS and Aging. AIDS (2004) 1.07
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Recurrent varicella-zoster virus myelitis in an immunocompetent patient. Eur Neurol (2004) 1.00
Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS (2015) 0.96
Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child. J Child Neurol (2012) 0.94
Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci (2002) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
The bone marrow, B cells, and JC virus. J Neurovirol (2008) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
Steroids for PML-IRIS: a double-edged sword? Neurology (2009) 0.89
Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneap Minn) (2015) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr Opin Neurol (2011) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. Am J Otolaryngol (2010) 0.86
Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS (2016) 0.85
Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.85
Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. Curr Treat Options Neurol (2012) 0.85
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy (2006) 0.85
Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J (2002) 0.84
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS (2003) 0.83
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol (2015) 0.83
White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. AIDS (2016) 0.82
Alien hand syndrome. Neurology (2006) 0.81
Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs (2015) 0.81
Spinal epidural abscess. Curr Infect Dis Rep (2014) 0.81
Substantia nigra depigmentation and exposure to encephalitis lethargica. Ann Neurol (2012) 0.81
Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia. PLoS One (2012) 0.80
Disease-modifying drugs for multiple sclerosis and JC virus expression. J Neurovirol (2012) 0.79
The manifold faces of PML and the challenge of diagnosis. Neurology (2011) 0.79
Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology (2003) 0.79
The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep (2011) 0.79
An international screening tool for HIV dementia. AIDS (2005) 0.78
Reply to "'Thinking without thinking' about natalizumab and PML". J Neurol Sci (2007) 0.78
Autoimmune markers in HIV-associated dementia. J Neuroimmunol (2003) 0.78
White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS (2016) 0.77
HIV and the central nervous system. Compr Ther (2002) 0.77
Primary lateral sclerosis with HIV-1 infection. Neurology (2008) 0.77
Too much of a good thing? IRIS with natalizumab-associated PML. Neurology (2011) 0.77
Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol (2004) 0.76
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. AIDS (2010) 0.76
Parinaud syndrome heralding MS. Neurology (2003) 0.75
Memory and the mammillothalamic tract. AJNR Am J Neuroradiol (2004) 0.75
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol (2014) 0.75
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? Neurology (2007) 0.75
Volitional opsoclonus. Neurology (2005) 0.75
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol (2014) 0.75
Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report. J Neurovirol (2012) 0.75
Neuro-AIDS in the developing world. Neurology (2012) 0.75
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT. Clin Neurol Neurosurg (2008) 0.75
Homonymous hemianopsia complicating treatment of postoperative epistaxis. Neurology (2006) 0.75
Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep (2013) 0.75
The interface of infectious disease and neuro-ophthalmology. J Neuroophthalmol (2012) 0.75
Primary central nervous system lymphoma. Handb Clin Neurol (2007) 0.75
Other opportunistic infections of the central nervous system in AIDS. Handb Clin Neurol (2007) 0.75
Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS (2017) 0.75
A giant MS plaque mimicking PML during natalizumab treatment. J Neurol Sci (2010) 0.75
Acute central cord syndrome with bodybuilder sign. Clin Neurol Neurosurg (2007) 0.75
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. J Neurovirol (2002) 0.75
Teaching neuroimages: pneumocephalus due to bacterial meningitis. Neurology (2009) 0.75
Infectious myelopathies. Continuum (Minneap Minn) (2011) 0.75
Progressive multifocal leukoencephalopathy. Handb Clin Neurol (2007) 0.75
Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy. Antivir Ther (2011) 0.75